Hiwada K - Search Results

1

Circulating interleukin-6 levels in patients with bronchial asthma.

Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, Fujioka S, Ishida S, Hiwada K. Yokoyama A, et al. Among authors: hiwada k. Am J Respir Crit Care Med. 1995 May;151(5):1354-8. doi: 10.1164/ajrccm.151.5.7735584. Am J Respir Crit Care Med. 1995. PMID: 7735584

2

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Ohnishi H, et al. Among authors: hiwada k. Am J Respir Crit Care Med. 2002 Feb 1;165(3):378-81. doi: 10.1164/ajrccm.165.3.2107134. Am J Respir Crit Care Med. 2002. PMID: 11818324

3

IgG and IgM rheumatoid factor levels parallel interleukin-6 during the vasculitic phase in a patient with Churg-Strauss syndrome.

Yokoyama A, Kohno N, Fujino S, Inoue Y, Hiwada K. Yokoyama A, et al. Among authors: hiwada k. Intern Med. 1995 Jul;34(7):646-8. doi: 10.2169/internalmedicine.34.646. Intern Med. 1995. PMID: 7496076 Free article.

4

Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells.

Fujino S, Yokoyama A, Kohno N, Hiwada K. Fujino S, et al. Among authors: hiwada k. Am J Respir Cell Mol Biol. 1996 Jun;14(6):508-15. doi: 10.1165/ajrcmb.14.6.8652179. Am J Respir Cell Mol Biol. 1996. PMID: 8652179

5

Soluble interleukin-6 receptor levels in pleural effusions.

Yokoyama A, Kohno N, Fujino S, Abe M, Ishida O, Hiwada K. Yokoyama A, et al. Among authors: hiwada k. Respir Med. 1996 Jul;90(6):329-32. doi: 10.1016/s0954-6111(96)90127-4. Respir Med. 1996. PMID: 8759474 Free article.

6

Circulating levels of soluble interleukin-6 receptor in patients with bronchial asthma.

Yokoyama A, Kohno N, Sakai K, Kondo K, Hirasawa Y, Hiwada K. Yokoyama A, et al. Among authors: hiwada k. Am J Respir Crit Care Med. 1997 Nov;156(5):1688-91. doi: 10.1164/ajrccm.156.5.9610070. Am J Respir Crit Care Med. 1997. PMID: 9372694

7

Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.

Kohno N, Yokoyama A, Hirasawa Y, Kondo K, Fujino S, Abe M, Hiwada K. Kohno N, et al. Among authors: hiwada k. Respir Med. 1997 Oct;91(9):558-61. doi: 10.1016/s0954-6111(97)90090-1. Respir Med. 1997. PMID: 9415357 Free article.

8

Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis.

Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, Hirasawa Y, Hiwada K. Yokoyama A, et al. Among authors: hiwada k. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1680-4. doi: 10.1164/ajrccm.158.5.9803115. Am J Respir Crit Care Med. 1998. PMID: 9817725

9

[Interleukin-6/soluble interleukin-6 receptor].

Yokoyama A, Hiwada K. Yokoyama A, et al. Among authors: hiwada k. Nihon Rinsho. 1999 Nov;57 Suppl:783-6. Nihon Rinsho. 1999. PMID: 10635969 Review. Japanese. No abstract available.

10

Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.

Hirasawa Y, Kohno N, Yokoyama A, Kondo K, Hiwada K, Miyake M. Hirasawa Y, et al. Among authors: hiwada k. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):589-94. doi: 10.1164/ajrccm.161.2.9905028. Am J Respir Crit Care Med. 2000. PMID: 10673204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page